Evaluation of estrogenic/antiestrogenic activity of ellagic acid via the estrogen receptor subtypes ERα and ERβ

Journal of Agricultural and Food Chemistry

Volumn 53, Issue 20, 2005, Pages 7715-7720

  Papoutsi, Zoi ^a   Kassi, Eva ^a   Tsiapara, Anna ^a   Fokialakis, Nikolas ^b   Chrousos, George P ^c   Moutsatsou, Paraskevi ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

Author keywords

Ellagic acid; Estrogen receptor alpha; Estrogen receptor beta; Osteoblasts; Selective estrogen receptor modulator

Indexed keywords

ANTIESTROGEN; ELLAGIC ACID; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA;

ARTICLE; BONE MINERALIZATION; BREAST TUMOR; CELL LINE; DRUG EFFECT; ENDOMETRIUM TUMOR; FEMALE; GENETIC TRANSFECTION; GENETICS; HELA CELL; HUMAN; OSTEOBLAST; PHYSIOLOGY; TUMOR CELL LINE;

BREAST NEOPLASMS; CALCIFICATION, PHYSIOLOGIC; CELL LINE; CELL LINE, TUMOR; ELLAGIC ACID; ENDOMETRIAL NEOPLASMS; ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; FEMALE; HELA CELLS; HUMANS; OSTEOBLASTS; TRANSFECTION;

MINK CELL FOCUS-FORMING VIRUS;

EID: 27144445277     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf0510539     Document Type: Article

References (41)

1. Yilmaz, Y.; Toledo, R. T. Major flavonoids in grape seeds and skins: Antioxidant capacity of catechin, epicatechin, and gallic acid. J. Agric. Food. Chem. 2004, 52, 255-260.
2. Hannum, S. M. Potential impact of strawberries on human health: A review of the science. Crit. Rev. Food. Sci. Nutr. 2004, 44, 1-17.
3. Herrera, M. C.; Luque De Castro, M. D. Ultrasound-assisted extraction for the analysis of phenolic compounds in strawberries. Anal. Bioanal. Chem. 2004, 379, 1106-1112.
4. Saleem, A.; Husheem, M.; Harkonen, P.; Pihlaja, K. Inhibition of cancer cell growth by crude extract and the phenolics of Terminalia chebula Retz. fruit. J. Ethnopharmacol. 2002, 81, 327-336.
5. Mertens-Talcott, S. U.; Talcott, S/T.; Percival, S. S. Low concentrations of quercetin and ellagic acid synergistically influence proliferation, cytotoxicity and apoptosis in MOLT-4 human leukemia cells. J. Nutr. 2003, 133, 2669-2674.
6. Festa, F.; Aglitti, T.; Duranti, G.; Ricordy, R.; Perticone, P.; Cozzi, R. Strong antioxidant activity of ellagic acid in mammalian cells in vitro revealed by the comet assay. Anticancer Res. 2001, 21, 3903-3908.
7. Chakraborty, S.; Roy, M.; Bhattacharya, R. K. Prevention and repair of DNA damage by selected phytochemicals as measured by single cell gel electrophoresis. J. Environ. Pathol. Toxicol. Oncol. 2004, 23, 215-226.
8. Anderson, K. J.; Teuber, S. S.; Gobeille, A.; Cremin, P.; Waterhouse, A. L.; Steinberg, F. M. Walnut polyphenolics inhibit in vitro human plasma and LDL oxidation. J. Nutr. 2001, 131, 2837-2842.
9. Buniatian, G. H. Stages of activation of hepatic stellate cells: Effects of ellagic acid, an inhibitor of liver fibrosis, on their differentiation in culture. Cell. Prolif. 2003, 36, 307-319.
10. Narayanan, B. A.; Re, G. G. IGF-II down regulation associated cell cycle arrest in colon cancer cells exposed to phenolic antioxidant ellagic acid. Anticancer Res. 2001, 21, 359-364.
11. Narayanan, B. A.; Narayanan, N. K.; Stoner, G. D.; Bullock, B. P. Interactive gene expression pattern in prostate cancer cells exposed to phenolic antioxidants. Life Sci. 2002, 70, 1821-1839.
12. Kris-Etherton, P. M.; Hecker, K. D.; Bonanome, A.; Coval, S. M.; Binkoski, A. E.; Hilpert, K. F.; Griel, A. E.; Etherton, T. D. Bioactive compounds in foods: Their role in the prevention of cardiovascular disease and cancer. Am. J. Med. 2002, 113, 71S-88S.
13. Middleton, E., Jr.; Kandaswami, C.; Theoharides, T. C. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol. Rev. 2000, 52, 673-751.
14. Wuttke, W.; Jarry, H.; Becker, T.; Schultens, A.; Christoffel, V.; Gorkow, C.; Seidlova-Wuttke D. Phytoestrogens: Endocrine disrupters or replacement for hormone replacement therapy? Maturitas. 2003, 44, S9-S20.
15. Lissin, L. W.; Cooke, J. P. Phytoestrogens and cardiovascular health. J. Am. Coll. Cardiol. 2000, 35, 1403-1410.
16. Ewies, A. A. Phytoestrogens in the management of the menopause: Up-to-date. Obstet. Gynecol. Surv. 2002, 57, 306-313.
17. Brzezinski, A.; Debi, A. Phytoestrogens: the "natural" selective estrogen receptor modulators? Eur. J. Obstet. Gynecol. Reprod. Biol. 1999, 85, 47-51.
18. Nilsson, S.; Makela, S.; Treuter, E.; Tujague, M.; Thomsen, J.; Andersson, G.; Enmark, E.; Pettersson, K.; Warner, M.; Gustafsson, J. A. Mechanisms of estrogen action. Physiol. Rev. 2001, 81, 1535-1565.
19. Matthews, J.; Gustafsson, J. A. Estrogen signaling: A subtle balance between ER alpha and ER beta. Mol. Interv. 2003, 3, 281-292.
20. Weihua, Z.; Andersson, S.; Cheng, G.; Simpson, E. R.; Warner, M.; Gustafsson, JA. Update on estrogen signaling. FEBS Lett. 2003, 546, 17-24.
21. Kuiper, G. G.; Lemmen, J. G.; Carlsson, B.; Corton, J. C.; Safe, S. H.; van der Saag, P. T.; van der Burg, B.; Gustafsson, J. A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998, 139, 4252-4263.
22. Pratt, S. E.; Pollak, M. N. Estrogen and antiestrogen modulation of MCF-7 human breast cancer cell proliferation is associated with specific alterations in accumulation of insulin-like growth factor binding proteins in conditioned media. Cancer Res 1993, 53, 5193-5198.
23. Dang, Z. C.; van Beznooijen, R. L.; Karperien, M.; Papapoulos, S. E.; Loewik, C. W. G. M. Exposure of KS483 cells to estrogen enhances osteogenesis and inhibits adipogenesis. J. Bone Miner. Res. 2002, 17, 394-405.
24. Denizof, F.; Lang, R. Rapid colorimetric assay for cell growth and survival: Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Methods 1986, 89, 271-277.
25. Nawwar, M. A. M.; Hussein, S. A. M.; Merfort, I. NMR spectral analysis of polyphenols from Punica granatum. Phytochemistry 1994, 36, 793-798.
26. Papoutsi, Z.; Kassi, E.; Papaevangeliou, D.; Pratsinis, H.; Zoumpourlis, V.; Halabalaki, M.; Mitakou, S.; Kalofoutis, A.; Moutsatsou P. Plant 2-arylobenzofurans demonstrate a selective estrogen receptor modulator profile. Steroids 2004, 69, 727-734.
27. Kassi, E.; Papoutsi, Z.; Fokialakis, N.; Messari, I.; Mitakou, S.; Moutsatsou, P. Greek plant extracts exhibit selective estrogen receptor modulator (SERM)-like properties. J. Agric. Food. Chem. 2004, 52, 6956-6961.
28. Barkhem, T.; Carlsson, B.; Nilsson, Y.; Enmark, E.; Gustafsson, J. A.; Nilsson, S. Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists. Mol. Pharmacol. 1998, 54, 105-112.
29. McInerney E. M.; Katzenellenbogen, B. S. Different regions in activation function-1 of the human estrogen receptor required for antiestrogen- and estradiol-dependent transcription activation. J. Biol. Chem. 1996, 271, 24172-24178.
30. Kuruto-Niwa, R.; Inoue, S.; Ogawa, S.; Muramatsu, M.; Nozawa, R. Effects of tea catechins on the ERE-regulated estrogenic activity. J. Agric. Food Chem. 2000, 48, 6355-6361
31. Bowers, J. L.; Tyulmenkov, V. V.; Jernigan, S. C.; Klinge, C. M. Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta. Endocrinology 2000, 141, 3657-3667.
32. Cowley, S. M.; Parker, M. G. A comparison of transcriptional activation by ER alpha and ER beta. J. Steroid Biochem. Mol. Biol. 1999, 69, 165-175.
33. Hall, J. M.; McDonnell, D. P. The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology 1999, 140, 5566-5578.
34. Usui, T.; Ikeda, Y.; Tagami, T.; Matsuda, K.; Moriyama, K.; Yamada, K.; Kuzuya, H.; Kohno, S.; Shimatsu, A. The phytochemical lindleyin, isolated from Rhei rhizoma, mediates hormonal effects through estrogen receptors. J. Endocrinol. 2002, 175, 289-296.
35. Tamir, S.; Eizenberg, M.; Somjen, D.; Izrael, S.; Vaya, J. Estrogen-like activity of glabrene and other constituents isolated from licorice root. J. Steroid. Biochem. Mol. Biol. 2001, 78, 291-298.
36. Burow, M. E.; Boue, S. M.; Collins-Burow, B. M.; Melnik, L. I.; Duong, B. N.; Carter-Wientjes, C. H.; Li, S.; Wiese, T. E.; Cleveland, T. E.; McLachlan, J. A. Phytochemical glyceollins, isolated from soy, mediate antihormonal effects through estrogen receptor alpha and beta. J. Clin. Endocrinol. Metab. 2001, 86, 1750-1758.
37. Pearce, V.; Nawaz, Z.; Xiao, W.; Wiedenfeld, D.; Boyle, N.; Smith, D. 4-ethoxymethylphenol: A novel phytoestrogen that acts as an agonist for human estrogen receptors. J. Steroid. Biochem. Mol. Biol. 2003, 84, 431-439.
38. Schwartz, J. A.; Liu, G.; Brooks, S. C. Genistein-mediated attenuation of tamoxifen-induced antagonism from estrogen receptor-regulated genes. Biochem. Biophys. Res. Commun. 1998, 253, 38-43.
39. Abe, I.; Umehara, K.; Morita, R.; Nemoto, K.; Degawa, M.; Noguchi, H. Green tea polyphenols as potent enhancers of glucocorticoid-induced mouse mammary tumor virus gene expression. Biochem. Biophys. Res. Commun. 2001, 281, 122-125.
40. Abe, I.; Seki, T.; Noguchi, H. Potent and selective inhibition of squalene epoxidase by synthetic galloyl esters. Biochem. Biophys. Res. Commun. 2000, 270, 137-140.
41. Tsai, Y. J.; Aoki, T.; Maruta, H.; Abe, H.; Sakagami, H.; Hatano, T.; Okuda, T.; Tanuma, S. Mouse mammary tumor virus gene expression is suppressed by oligomeric ellagitannins, novel inhibitors of poly(ADP-ribose) glycohydrolase. J. Biol. Chem. 1992, 267, 14436-14442.